ArticleBMC pregnancy and childbirth2026
Group B Streptococcus colonization, antibiotic resistance, and maternal-neonatal outcomes in late pregnancy: a retrospective study from 2017 to 2024.
Article in BMC pregnancy and childbirth, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
objectiveTo assess Group B Streptococcus (GBS) colonization, detection methods, and antibiotic susceptibility in late pregnancy and provide evidence to improve screening strategies and reduce perinatal infection risk.
methodsThis retrospective study included pregnant women screened for GBS between 2017 and 2024 at a tertiary hospital in Yunnan, China. Vaginal specimens were tested using culture or qPCR. Antibiotic susceptibility was evaluated for culture-positive isolates. Logistic regression was used to identify risk factors, and maternal and neonatal outcomes were compared between colonized and non-colonized women.
resultsThe colonization rate was 3.9% among 5,184 women tested by culture and 7.3% among 6,303 women tested by qPCR. qPCR detection demonstrated significantly higher detection rates compared to culture-based methods in a paired comparison (n = 3242). All isolates were sensitive to penicillin G, vancomycin, and ampicillin, while high resistance was observed to clindamycin (73.7%), erythromycin (69.7%) and tetracycline (61.1%). Sensitivity to levofloxacin and moxifloxacin was 51.7%, with rare intermediate isolates. No resistance to linezolid, tigecycline, daptomycin, or vancomycin was detected. More than two miscarriages, gestational diabetes, and vaginitis were independent risk factors for GBS colonization. Colonized women had higher rates of premature rupture of membranes and chorioamnionitis, and their neonates had higher odds of pathological jaundice and fetal distress.
conclusionGBS colonization in this region was lower than national estimates, while qPCR offers markedly improved detection compared with culture. Local isolates show full susceptibility to penicillin, supporting its continued use as the first-line agent for intrapartum prophylaxis. Strengthened surveillance of colonization and resistance patterns, together with targeted prevention strategies, is warranted to reduce perinatal infection risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.